SLNHP(SLNHP)
SLNHP
No analyst ratings available
No analyst price targets available for SLNHP
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $60M | $77M |
| Low | $60M | $77M |
| High | $60M | $77M |
| EBITDA Avg | $-30M | $-38M |
| Low | $-30M | $-38M |
| High | $-30M | $-38M |
| EBIT Avg | $-51M | $-65M |
| Low | $-51M | $-65M |
| High | $-51M | $-65M |
| Net Income Avg | $-13M | $-8M |
| Low | $-13M | $-8M |
| High | $-13M | $-8M |
| EPS Avg | $-0.45 | $-0.27 |
| Low | $-0.45 | $-0.27 |
| High | $-0.45 | $-0.27 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $17M | $18M | $19M | $19M | $19M | $19M |
| Low | $17M | $18M | $19M | $19M | $19M | $19M |
| High | $17M | $18M | $19M | $19M | $19M | $19M |
| EBITDA Avg | $-8M | $-9M | $-9M | $-10M | $-10M | $-9M |
| Low | $-8M | $-9M | $-9M | $-10M | $-10M | $-9M |
| High | $-8M | $-9M | $-9M | $-10M | $-10M | $-9M |
| EBIT Avg | $-14M | $-15M | $-16M | $-16M | $-16M | $-16M |
| Low | $-14M | $-15M | $-16M | $-16M | $-16M | $-16M |
| High | $-14M | $-15M | $-16M | $-16M | $-16M | $-16M |
| Net Income Avg | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M |
| Low | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M |
| High | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M |
| EPS Avg | $-0.08 | $-0.08 | $-0.07 | $-0.07 | $-0.07 | $-0.07 |
| Low | $-0.08 | $-0.08 | $-0.07 | $-0.07 | $-0.07 | $-0.07 |
| High | $-0.08 | $-0.08 | $-0.07 | $-0.07 | $-0.07 | $-0.07 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |